Filing Details
- Accession Number:
- 0001127602-19-007865
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-25 09:36:13
- Reporting Period:
- 2015-02-10
- Accepted Time:
- 2019-02-25 09:36:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 794172 | Meridian Bioscience Inc | VIVO | In Vitro & In Vivo Diagnostic Substances (2835) | 310888197 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1614529 | E Dwight Ellingwood | 3471 River Hills Drive Cincinnati OH 45244 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-02-10 | 33 | $18.20 | 3,013 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2015-05-11 | 32 | $18.51 | 3,045 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2015-08-10 | 32 | $18.69 | 3,077 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2015-11-23 | 32 | $19.27 | 3,109 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-02-12 | 32 | $19.62 | 3,141 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-05-16 | 33 | $19.06 | 3,174 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-08-15 | 32 | $19.50 | 6,206 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-11-28 | 38 | $17.07 | 6,244 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-02-13 | 41 | $12.93 | 7,305 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-15 | 36 | $14.90 | 7,341 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-08-14 | 39 | $13.94 | 7,380 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-11-28 | 38 | $14.56 | 7,418 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-02-13 | 39 | $14.13 | 7,457 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-05-15 | 40 | $13.88 | 7,497 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-08-16 | 38 | $14.91 | 7,535 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-28 | 31 | $18.42 | 8,566 | No | 4 | P | Direct | |
| Common Stock | Disposition | 2019-02-21 | 981 | $0.00 | 0 | No | 4 | J | Direct | |
| Common Stock | Acquisiton | 2019-02-21 | 981 | $0.00 | 9,547 | No | 4 | J | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | J | Direct | |
| No | 4 | J | Direct |
Footnotes
- Share purchases reflected on this Form were acquired via a Dividend Reinvestment Plan ("DRIP") beginning in February 2015 and ceasing in November 2018.
- Following the January 24, 2019 grant of 981 restricted stock units (as reported on Form 4 filed January 28, 2019), Common Stock holdings currently total 9,547.
Billionaire Hedge Funds
